Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

NCT ID: NCT00781391

Last Updated: 2019-03-05

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

21105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to demonstrate the safety and efficacy profile, in two different dose regimens of Edoxaban (DU-176b), (an investigational new drug being tested for the prevention of stroke/systemic embolic events (SEE)), in individuals with atrial fibrillation. Patients will be randomized to one of three treatment groups: High Dose Regimen, Low Dose Regimen, \& Warfarin. The expected duration of the study is 24 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Atrial Fibrillation Embolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Warfarin/placebo edoxaban

Warfarin tablets plus placebo Edoxaban tablets

Group Type ACTIVE_COMPARATOR

warfarin tablets

Intervention Type DRUG

Warfarin tablets plus Edoxaban placebo tablets each taken once daily for 24 months

placebo edoxaban

Intervention Type DRUG

placebo edoxaban

high dose edoxaban/placebo warfarin

Edoxaban tablets (60mg) plus warfarin placebo tablets

Group Type EXPERIMENTAL

Edoxaban tablets (high dose regimen-60mg)

Intervention Type DRUG

Edoxaban tablets plus warfarin placebo tablets each taken once daily for 24 months

placebo warfarin

Intervention Type DRUG

placebo warfarin

low dose edoxaban/placebo warfarin

Edoxaban tablets (30mg) plus warfarin placebo tablets

Group Type EXPERIMENTAL

Edoxaban tablets (low dose regimen-30mg)

Intervention Type DRUG

Edoxaban tablets plus warfarin placebo tablets each taken once daily for 24 months

placebo warfarin

Intervention Type DRUG

placebo warfarin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

warfarin tablets

Warfarin tablets plus Edoxaban placebo tablets each taken once daily for 24 months

Intervention Type DRUG

Edoxaban tablets (high dose regimen-60mg)

Edoxaban tablets plus warfarin placebo tablets each taken once daily for 24 months

Intervention Type DRUG

Edoxaban tablets (low dose regimen-30mg)

Edoxaban tablets plus warfarin placebo tablets each taken once daily for 24 months

Intervention Type DRUG

placebo warfarin

placebo warfarin

Intervention Type DRUG

placebo edoxaban

placebo edoxaban

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 21 years of age or older; male or female.
* Able to provide written informed consent.
* History of documented AF within the prior 12 months
* A moderate to high risk of stroke, as defined by CHADS2 index score of at least 2

Exclusion Criteria

* Transient atrial fibrillation secondary to other reversible disorders
* Subjects with moderate or severe mitral stenosis, unresected atrial myxoma, or a mechanical heart valve
* Subjects with any contraindication for anticoagulant agents;
* Subjects with conditions associated with high risk of bleeding or have known or suspected hereditary or acquired bleeding disorders
* Females of childbearing potential including the following:

* Females with a history of tubal-ligation
* Females less than 2 years post-menopausal
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The TIMI Study Group

OTHER

Sponsor Role collaborator

Daiichi Sankyo

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birmingham, Alabama, United States

Site Status

Mobile, Alabama, United States

Site Status

Gilbert, Arizona, United States

Site Status

Glendale, Arizona, United States

Site Status

Lake Havasu City, Arizona, United States

Site Status

Sierra Vista, Arizona, United States

Site Status

Tempe, Arizona, United States

Site Status

Tucson, Arizona, United States

Site Status

Harrisburg, Arkansas, United States

Site Status

Hot Springs, Arkansas, United States

Site Status

Little Rock, Arkansas, United States

Site Status

Alhambra, California, United States

Site Status

Anaheim, California, United States

Site Status

Burbank, California, United States

Site Status

Chula Vista, California, United States

Site Status

Encinitas, California, United States

Site Status

Fountain Valley, California, United States

Site Status

Glendale, California, United States

Site Status

Healdsburg, California, United States

Site Status

Lakewood, California, United States

Site Status

Long Beach, California, United States

Site Status

Los Alamitos, California, United States

Site Status

Los Angeles, California, United States

Site Status

Los Banos, California, United States

Site Status

Mather, California, United States

Site Status

Merced, California, United States

Site Status

Newport Beach, California, United States

Site Status

Oceanside, California, United States

Site Status

Pacific Palisades, California, United States

Site Status

Palm Springs, California, United States

Site Status

Pismo Beach, California, United States

Site Status

Redondo Beach, California, United States

Site Status

Sacramento, California, United States

Site Status

San Diego, California, United States

Site Status

Santa Rosa, California, United States

Site Status

Torrance, California, United States

Site Status

Ventura, California, United States

Site Status

Aurora, Colorado, United States

Site Status

Colorado Springs, Colorado, United States

Site Status

Denver, Colorado, United States

Site Status

Englewood, Colorado, United States

Site Status

Greeley, Colorado, United States

Site Status

Bridgeport, Connecticut, United States

Site Status

Guilford, Connecticut, United States

Site Status

Hamden, Connecticut, United States

Site Status

Manchester, Connecticut, United States

Site Status

New Haven, Connecticut, United States

Site Status

North Haven, Connecticut, United States

Site Status

Shelton, Connecticut, United States

Site Status

Stamford, Connecticut, United States

Site Status

Trumbull, Connecticut, United States

Site Status

Newark, Delaware, United States

Site Status

Washington D.C., District of Columbia, United States

Site Status

Aventura, Florida, United States

Site Status

Chipley, Florida, United States

Site Status

Clearwater, Florida, United States

Site Status

Daytona Beach, Florida, United States

Site Status

Daytona Beach, Florida, United States

Site Status

DeBary, Florida, United States

Site Status

Deerfield Beach, Florida, United States

Site Status

Delray Beach, Florida, United States

Site Status

Delray Beach, Florida, United States

Site Status

Hialeah, Florida, United States

Site Status

Hollywood, Florida, United States

Site Status

Jacksonville, Florida, United States

Site Status

Jacksonville Beach, Florida, United States

Site Status

Jupiter, Florida, United States

Site Status

Leesburg, Florida, United States

Site Status

Melbourne, Florida, United States

Site Status

Miami, Florida, United States

Site Status

Miami, Florida, United States

Site Status

Naples, Florida, United States

Site Status

Orange Park, Florida, United States

Site Status

Orlando, Florida, United States

Site Status

Ormond Beach, Florida, United States

Site Status

Panama City, Florida, United States

Site Status

Pembroke Pines, Florida, United States

Site Status

Pensacola, Florida, United States

Site Status

Plantation, Florida, United States

Site Status

Port Charlotte, Florida, United States

Site Status

Rockledge, Florida, United States

Site Status

Saint Augustine, Florida, United States

Site Status

Sarasota, Florida, United States

Site Status

St. Petersburg, Florida, United States

Site Status

Stuart, Florida, United States

Site Status

Tamarac, Florida, United States

Site Status

Tampa, Florida, United States

Site Status

The Villages, Florida, United States

Site Status

Vero Beach, Florida, United States

Site Status

West Palm Beach, Florida, United States

Site Status

Athens, Georgia, United States

Site Status

Atlanta, Georgia, United States

Site Status

Conyers, Georgia, United States

Site Status

Covington, Georgia, United States

Site Status

Cumming, Georgia, United States

Site Status

Savannah, Georgia, United States

Site Status

Snellville, Georgia, United States

Site Status

Tucker, Georgia, United States

Site Status

Watkinsville, Georgia, United States

Site Status

Waycross, Georgia, United States

Site Status

Woodstock, Georgia, United States

Site Status

Honolulu, Hawaii, United States

Site Status

Boise, Idaho, United States

Site Status

Hayden Lake, Idaho, United States

Site Status

Bannockburn, Illinois, United States

Site Status

Belleville, Illinois, United States

Site Status

Chicago, Illinois, United States

Site Status

Elgin, Illinois, United States

Site Status

Joliet, Illinois, United States

Site Status

Libertyville, Illinois, United States

Site Status

Maywood, Illinois, United States

Site Status

Melrose Park, Illinois, United States

Site Status

Oak Lawn, Illinois, United States

Site Status

Springfield, Illinois, United States

Site Status

Winfield, Illinois, United States

Site Status

Bloomington, Indiana, United States

Site Status

Munster, Indiana, United States

Site Status

Ames, Iowa, United States

Site Status

Council Bluffs, Iowa, United States

Site Status

Iowa City, Iowa, United States

Site Status

Shell Rock, Iowa, United States

Site Status

Wichita, Kansas, United States

Site Status

Bowling Green, Kentucky, United States

Site Status

Campbellsville, Kentucky, United States

Site Status

Elizabethtown, Kentucky, United States

Site Status

Richmond, Kentucky, United States

Site Status

Marrero, Louisiana, United States

Site Status

West Monroe, Louisiana, United States

Site Status

West Monroe, Louisiana, United States

Site Status

Auburn, Maine, United States

Site Status

Biddeford, Maine, United States

Site Status

Baltimore, Maryland, United States

Site Status

Bel Air, Maryland, United States

Site Status

Bethesda, Maryland, United States

Site Status

Lexington Park, Maryland, United States

Site Status

Rockville, Maryland, United States

Site Status

Salisbury, Maryland, United States

Site Status

Towson, Maryland, United States

Site Status

Westminster, Maryland, United States

Site Status

Ayer, Massachusetts, United States

Site Status

Boston, Massachusetts, United States

Site Status

Concord, Massachusetts, United States

Site Status

East Bridgewater, Massachusetts, United States

Site Status

Haverhill, Massachusetts, United States

Site Status

Methuen, Massachusetts, United States

Site Status

Worcester, Massachusetts, United States

Site Status

Bay City, Michigan, United States

Site Status

Benzonia, Michigan, United States

Site Status

Chelsea, Michigan, United States

Site Status

Commerce, Michigan, United States

Site Status

Detroit, Michigan, United States

Site Status

Grand Rapids, Michigan, United States

Site Status

Interlochen, Michigan, United States

Site Status

Kalamazoo, Michigan, United States

Site Status

Lapeer, Michigan, United States

Site Status

Midland, Michigan, United States

Site Status

Rochester Hills, Michigan, United States

Site Status

Saginaw, Michigan, United States

Site Status

Troy, Michigan, United States

Site Status

Warren, Michigan, United States

Site Status

Golden Valley, Minnesota, United States

Site Status

Minneapolis, Minnesota, United States

Site Status

Saint Paul, Minnesota, United States

Site Status

Biloxi, Mississippi, United States

Site Status

Chesterfield, Missouri, United States

Site Status

Joplin, Missouri, United States

Site Status

Kansas City, Missouri, United States

Site Status

Saint Charles, Missouri, United States

Site Status

St Louis, Missouri, United States

Site Status

Kalispell, Montana, United States

Site Status

Fremont, Nebraska, United States

Site Status

Grand Island, Nebraska, United States

Site Status

Lincoln, Nebraska, United States

Site Status

Omaha, Nebraska, United States

Site Status

Henderson, Nevada, United States

Site Status

Belvidere, New Jersey, United States

Site Status

Brick, New Jersey, United States

Site Status

Bridgewater, New Jersey, United States

Site Status

Browns Mills, New Jersey, United States

Site Status

Cherry Hill, New Jersey, United States

Site Status

Elizabeth, New Jersey, United States

Site Status

Haddon Heights, New Jersey, United States

Site Status

Hamilton, New Jersey, United States

Site Status

Mine Hill, New Jersey, United States

Site Status

Ocean City, New Jersey, United States

Site Status

Passaic, New Jersey, United States

Site Status

Ridgewood, New Jersey, United States

Site Status

Somerset, New Jersey, United States

Site Status

Toms River, New Jersey, United States

Site Status

Albuquerque, New Mexico, United States

Site Status

Albany, New York, United States

Site Status

Brooklyn, New York, United States

Site Status

Buffalo, New York, United States

Site Status

Cortlandt Manor, New York, United States

Site Status

Hawthorne, New York, United States

Site Status

Jamaica, New York, United States

Site Status

Mineola, New York, United States

Site Status

New York, New York, United States

Site Status

North Massapequa, New York, United States

Site Status

Saratoga Springs, New York, United States

Site Status

Troy, New York, United States

Site Status

Cary, North Carolina, United States

Site Status

Chapel Hill, North Carolina, United States

Site Status

Charlotte, North Carolina, United States

Site Status

Greensboro, North Carolina, United States

Site Status

Mooresville, North Carolina, United States

Site Status

Morehead City, North Carolina, United States

Site Status

Morganton, North Carolina, United States

Site Status

Morganton, North Carolina, United States

Site Status

Oxford, North Carolina, United States

Site Status

Pinehurst, North Carolina, United States

Site Status

Statesville, North Carolina, United States

Site Status

Winston-Salem, North Carolina, United States

Site Status

Fargo, North Dakota, United States

Site Status

Oakes, North Dakota, United States

Site Status

Akron, Ohio, United States

Site Status

Canal Fulton, Ohio, United States

Site Status

Canton, Ohio, United States

Site Status

Cincinnati, Ohio, United States

Site Status

Cleveland, Ohio, United States

Site Status

Columbus, Ohio, United States

Site Status

Cuyahoga Falls, Ohio, United States

Site Status

Dayton, Ohio, United States

Site Status

Fairfield, Ohio, United States

Site Status

Marion, Ohio, United States

Site Status

Middletown, Ohio, United States

Site Status

Pitsburg, Ohio, United States

Site Status

Springfield, Ohio, United States

Site Status

Thornville, Ohio, United States

Site Status

Toledo, Ohio, United States

Site Status

Willoughby Hills, Ohio, United States

Site Status

Bartlesville, Oklahoma, United States

Site Status

Oklahoma City, Oklahoma, United States

Site Status

Bend, Oregon, United States

Site Status

Corvallis, Oregon, United States

Site Status

Altoona, Pennsylvania, United States

Site Status

Beaver, Pennsylvania, United States

Site Status

Chester, Pennsylvania, United States

Site Status

Clymer, Pennsylvania, United States

Site Status

Danville, Pennsylvania, United States

Site Status

Doylestown, Pennsylvania, United States

Site Status

Ephrata, Pennsylvania, United States

Site Status

Feasterville, Pennsylvania, United States

Site Status

Fleetwood, Pennsylvania, United States

Site Status

Greenville, Pennsylvania, United States

Site Status

Johnstown, Pennsylvania, United States

Site Status

Lancaster, Pennsylvania, United States

Site Status

Lewistown, Pennsylvania, United States

Site Status

Newport, Pennsylvania, United States

Site Status

Norristown, Pennsylvania, United States

Site Status

Philadelphia, Pennsylvania, United States

Site Status

Pittsburgh, Pennsylvania, United States

Site Status

Pottstown, Pennsylvania, United States

Site Status

Scranton, Pennsylvania, United States

Site Status

Sellersville, Pennsylvania, United States

Site Status

Somerset, Pennsylvania, United States

Site Status

State College, Pennsylvania, United States

Site Status

Uniontown, Pennsylvania, United States

Site Status

Wilkes-Barre, Pennsylvania, United States

Site Status

Wynnewood, Pennsylvania, United States

Site Status

Yardley, Pennsylvania, United States

Site Status

Providence, Rhode Island, United States

Site Status

Anderson, South Carolina, United States

Site Status

Charleston, South Carolina, United States

Site Status

Columbia, South Carolina, United States

Site Status

Florence, South Carolina, United States

Site Status

Greenville, South Carolina, United States

Site Status

Greer, South Carolina, United States

Site Status

Mt. Pleasant, South Carolina, United States

Site Status

Spartanburg, South Carolina, United States

Site Status

Summerville, South Carolina, United States

Site Status

Taylors, South Carolina, United States

Site Status

Walterboro, South Carolina, United States

Site Status

Rapid City, South Dakota, United States

Site Status

Columbia, Tennessee, United States

Site Status

Jackson, Tennessee, United States

Site Status

Johnson City, Tennessee, United States

Site Status

Nashville, Tennessee, United States

Site Status

Oak Ridge, Tennessee, United States

Site Status

Arlington, Texas, United States

Site Status

Austin, Texas, United States

Site Status

Carrollton, Texas, United States

Site Status

Corsicana, Texas, United States

Site Status

Dallas, Texas, United States

Site Status

Fort Worth, Texas, United States

Site Status

Georgetown, Texas, United States

Site Status

Grapevine, Texas, United States

Site Status

Houston, Texas, United States

Site Status

Lubbock, Texas, United States

Site Status

McAllen, Texas, United States

Site Status

Odessa, Texas, United States

Site Status

Plano, Texas, United States

Site Status

San Antonio, Texas, United States

Site Status

Tomball, Texas, United States

Site Status

Wichita Falls, Texas, United States

Site Status

Provo, Utah, United States

Site Status

West Valley City, Utah, United States

Site Status

Danville, Virginia, United States

Site Status

Hopewell, Virginia, United States

Site Status

Newport News, Virginia, United States

Site Status

Norfolk, Virginia, United States

Site Status

Richmond, Virginia, United States

Site Status

Springfield, Virginia, United States

Site Status

Suffolk, Virginia, United States

Site Status

Virginia Beach, Virginia, United States

Site Status

Winchester, Virginia, United States

Site Status

Bellevue, Washington, United States

Site Status

Kirkland, Washington, United States

Site Status

Renton, Washington, United States

Site Status

Seattle, Washington, United States

Site Status

Spokane, Washington, United States

Site Status

Tacoma, Washington, United States

Site Status

Clarksburg, West Virginia, United States

Site Status

Madison, Wisconsin, United States

Site Status

Manitowoc, Wisconsin, United States

Site Status

Menomonee Falls, Wisconsin, United States

Site Status

Bahía Blanca, , Argentina

Site Status

Buenos Aires, , Argentina

Site Status

Corrientes, , Argentina

Site Status

Córdoba, , Argentina

Site Status

Formosa, , Argentina

Site Status

Godoy Cruz, , Argentina

Site Status

Mar del Plata, , Argentina

Site Status

Mendoza, , Argentina

Site Status

Paraguay, , Argentina

Site Status

Provincia de Chaco, , Argentina

Site Status

Provincia de Rio Negro, , Argentina

Site Status

Provincia de Salta, , Argentina

Site Status

San Luis, , Argentina

Site Status

San Miguel de Tucumán, , Argentina

Site Status

San Salvador de Jujuy, , Argentina

Site Status

Santa Fe, , Argentina

Site Status

Sante Fe, , Argentina

Site Status

Broken Hill, New South Wales, Australia

Site Status

East Gosford, New South Wales, Australia

Site Status

Carina Heights, Queensland, Australia

Site Status

Milton, Queensland, Australia

Site Status

Adelaide, South Australia, Australia

Site Status

Frankston, Victoria, Australia

Site Status

Ashford, , Australia

Site Status

Camperdown, , Australia

Site Status

Elizabeth Vale, , Australia

Site Status

Joondalup, , Australia

Site Status

Melbourne, , Australia

Site Status

Parkville, , Australia

Site Status

Perth, , Australia

Site Status

Antwerp, , Belgium

Site Status

Arlon, , Belgium

Site Status

Bruges, , Belgium

Site Status

Brussels, , Belgium

Site Status

Genk, , Belgium

Site Status

Hasselt, , Belgium

Site Status

Leuven, , Belgium

Site Status

Liège, , Belgium

Site Status

Mechelen, , Belgium

Site Status

Merksem, , Belgium

Site Status

Moerkerke, , Belgium

Site Status

Montegnée, , Belgium

Site Status

Mousron, , Belgium

Site Status

Torhout, , Belgium

Site Status

Veurne, , Belgium

Site Status

Wetteren, , Belgium

Site Status

Belo Horizonte, , Brazil

Site Status

Blumenau, , Brazil

Site Status

Brasília, , Brazil

Site Status

Campina Grande do Sul, , Brazil

Site Status

Campinas, , Brazil

Site Status

Caxias do Sul, , Brazil

Site Status

Curitiba, , Brazil

Site Status

Goiânia, , Brazil

Site Status

Lajeados, , Brazil

Site Status

Maceió, , Brazil

Site Status

Marília, , Brazil

Site Status

Passo Fundo, , Brazil

Site Status

Porto Alegre, , Brazil

Site Status

Recife, , Brazil

Site Status

Ribeirão Preto, , Brazil

Site Status

Rio de Janeiro, , Brazil

Site Status

Salvador, , Brazil

Site Status

Santo André, , Brazil

Site Status

São José, , Brazil

Site Status

São Paulo, , Brazil

Site Status

Uberlândia, , Brazil

Site Status

Burgas, , Bulgaria

Site Status

Dimitrovgrad, , Bulgaria

Site Status

Haskovo, , Bulgaria

Site Status

Pleven, , Bulgaria

Site Status

Plovdiv, , Bulgaria

Site Status

Rousse, , Bulgaria

Site Status

Sofia, , Bulgaria

Site Status

Varna, , Bulgaria

Site Status

Calgary, Alberta, Canada

Site Status

Campbell River, British Columbia, Canada

Site Status

Chilliwack, British Columbia, Canada

Site Status

Coquitlam, British Columbia, Canada

Site Status

Kamloops, British Columbia, Canada

Site Status

Kelowna, British Columbia, Canada

Site Status

New Westminster, British Columbia, Canada

Site Status

Penticton, British Columbia, Canada

Site Status

Quesnel, British Columbia, Canada

Site Status

Victoria, British Columbia, Canada

Site Status

Saint John, New Brunswick, Canada

Site Status

Bridgewater, Nova Scotia, Canada

Site Status

Halifax, Nova Scotia, Canada

Site Status

Liverpool, Nova Scotia, Canada

Site Status

Ajax, Ontario, Canada

Site Status

Beamsville, Ontario, Canada

Site Status

Brampton, Ontario, Canada

Site Status

Corunna, Ontario, Canada

Site Status

Greater Sudbury, Ontario, Canada

Site Status

Hamilton, Ontario, Canada

Site Status

Kitchener, Ontario, Canada

Site Status

Listowel, Ontario, Canada

Site Status

London, Ontario, Canada

Site Status

Oshawa, Ontario, Canada

Site Status

Ottawa, Ontario, Canada

Site Status

Richmond Hill, Ontario, Canada

Site Status

Sarnia, Ontario, Canada

Site Status

Scarborough Village, Ontario, Canada

Site Status

Toronto, Ontario, Canada

Site Status

Greenfield Park, Quebec, Canada

Site Status

Longueuil, Quebec, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Québec, Quebec, Canada

Site Status

Saint Georges de Beauce, Quebec, Canada

Site Status

Saint-Charles-Borromée, Quebec, Canada

Site Status

Saint-Jérôme, Quebec, Canada

Site Status

Saint-Lambert, Quebec, Canada

Site Status

Terrebonne, Quebec, Canada

Site Status

Trois-Rivières, Quebec, Canada

Site Status

Westmount, Quebec, Canada

Site Status

Saskatoon, Saskatchewan, Canada

Site Status

Mount Pearl, , Canada

Site Status

St. John's, , Canada

Site Status

Iquique, , Chile

Site Status

La Serena, , Chile

Site Status

Osorno, , Chile

Site Status

Port Montt, , Chile

Site Status

Rancagua, , Chile

Site Status

Santiago, , Chile

Site Status

Talcahuano, , Chile

Site Status

Temuco, , Chile

Site Status

Victoria, , Chile

Site Status

Viña del Mar, , Chile

Site Status

Baotou, , China

Site Status

Beijing, , China

Site Status

Changchun, , China

Site Status

Changsha, , China

Site Status

Chendu, , China

Site Status

Chongqing, , China

Site Status

Guangxi, , China

Site Status

Guangzhou, , China

Site Status

Hainan Province, , China

Site Status

Hangzhou, , China

Site Status

Harbin, , China

Site Status

Jinzhou, , China

Site Status

Lanzhou, , China

Site Status

Liaoning Province, , China

Site Status

Nanchang, , China

Site Status

Shaanxi Province, , China

Site Status

Shanghai, , China

Site Status

Shenyang, , China

Site Status

Shijiazhuang, , China

Site Status

Tianjin, , China

Site Status

Wenzhou, , China

Site Status

Wuhan, , China

Site Status

Antioquia, , Colombia

Site Status

Armenia, , Colombia

Site Status

Barranquilla, , Colombia

Site Status

Bogotá, , Colombia

Site Status

Bucaramanga, , Colombia

Site Status

Cartagena, , Colombia

Site Status

Envigado, , Colombia

Site Status

Manizales, , Colombia

Site Status

Medellín, , Colombia

Site Status

Dubrovnik, , Croatia

Site Status

Karlovac, , Croatia

Site Status

Koprivnica, , Croatia

Site Status

Krapinski Toplice, , Croatia

Site Status

Osijek, , Croatia

Site Status

Rijeka, , Croatia

Site Status

Slavonski Brod, , Croatia

Site Status

Split, , Croatia

Site Status

Varaždin, , Croatia

Site Status

Zadar, , Croatia

Site Status

Zagreb, , Croatia

Site Status

Benátky nad Jizerou, , Czechia

Site Status

Benešov, , Czechia

Site Status

Bílovec, , Czechia

Site Status

Brno, , Czechia

Site Status

Brno-Lesna, , Czechia

Site Status

Chrudim, , Czechia

Site Status

Český Krumlov, , Czechia

Site Status

Havlickux Brod, , Czechia

Site Status

Hradec Králové, , Czechia

Site Status

Hranice, , Czechia

Site Status

Jindřichův Hradec, , Czechia

Site Status

Kolín, , Czechia

Site Status

Kroměříž, , Czechia

Site Status

Mariánské Lázně, , Czechia

Site Status

Mladá Boleslav, , Czechia

Site Status

Náchod, , Czechia

Site Status

Ostrava, , Czechia

Site Status

Ostrava-Trebovice, , Czechia

Site Status

Pardubice, , Czechia

Site Status

Pilsen, , Czechia

Site Status

Prague, , Czechia

Site Status

Příbram, , Czechia

Site Status

Řevnice, , Czechia

Site Status

Semily, , Czechia

Site Status

Slaný, , Czechia

Site Status

Teplice, , Czechia

Site Status

Trutnov, , Czechia

Site Status

Ústí nad Labem, , Czechia

Site Status

Aarhus N, , Denmark

Site Status

Copenhagen, , Denmark

Site Status

Esbjerg, , Denmark

Site Status

Frederiksberg, , Denmark

Site Status

Glostrup Municipality, , Denmark

Site Status

Hellerup, , Denmark

Site Status

Holbæk, , Denmark

Site Status

Horsens, , Denmark

Site Status

Haabneeme, Harju, Estonia

Site Status

Puusepa, Tartu, Estonia

Site Status

Pärnu, , Estonia

Site Status

Tallinn, , Estonia

Site Status

Tartu, , Estonia

Site Status

Jyväskylä, , Finland

Site Status

Kuopio, , Finland

Site Status

Lappeenranta, , Finland

Site Status

Oulu, , Finland

Site Status

Seinäjoki, , Finland

Site Status

Tampere, , Finland

Site Status

Abbeville, , France

Site Status

Amiens, , France

Site Status

Brest, , France

Site Status

Cambrai, , France

Site Status

Clamart, , France

Site Status

La Roche-sur-Yon, , France

Site Status

Lille, , France

Site Status

Lyon, , France

Site Status

Massy, , France

Site Status

Nantes, , France

Site Status

Paris, , France

Site Status

Pau, , France

Site Status

Pessac, , France

Site Status

Poitiers, , France

Site Status

Tours, , France

Site Status

Valenciennes, , France

Site Status

Altenburg, , Germany

Site Status

Aschaffenburg, , Germany

Site Status

Augsburg, , Germany

Site Status

Bad Nauheim, , Germany

Site Status

Berlin, , Germany

Site Status

Bochum, , Germany

Site Status

Cloppenburg, , Germany

Site Status

Cologne, , Germany

Site Status

Dortmund, , Germany

Site Status

Dresden, , Germany

Site Status

Essen, , Germany

Site Status

Frankfurt, , Germany

Site Status

Giengen an der Brenz, , Germany

Site Status

Görlitz, , Germany

Site Status

Großheirath, , Germany

Site Status

Hamburg, , Germany

Site Status

Heidelberg, , Germany

Site Status

Heilbronn, , Germany

Site Status

Homburg, , Germany

Site Status

Ingelheim, , Germany

Site Status

Kallstadt, , Germany

Site Status

Kassel, , Germany

Site Status

Kiel-Kronshagen, , Germany

Site Status

Leipzig, , Germany

Site Status

Ludwigshafen, , Germany

Site Status

Lübeck, , Germany

Site Status

Magdeburg, , Germany

Site Status

Mainz, , Germany

Site Status

Mannheim, , Germany

Site Status

Markkleeberg, , Germany

Site Status

München, , Germany

Site Status

Nienburg, , Germany

Site Status

Northeinm, , Germany

Site Status

Offenbach-beiber, , Germany

Site Status

Potsdam, , Germany

Site Status

Rüdersdorf, , Germany

Site Status

Siegen, , Germany

Site Status

Stuhr, , Germany

Site Status

Ulm, , Germany

Site Status

Unterschneidheim, , Germany

Site Status

Wardenburg, , Germany

Site Status

Wermsdorf, , Germany

Site Status

Weyhe, , Germany

Site Status

Witten, , Germany

Site Status

Woerishofen, , Germany

Site Status

Wuppertal, , Germany

Site Status

Athens, , Greece

Site Status

Larissa, , Greece

Site Status

Rhodes, , Greece

Site Status

Rio-Patras, , Greece

Site Status

Thessaloniki, , Greece

Site Status

Trikala, , Greece

Site Status

Voula, , Greece

Site Status

Ciudad, , Guatemala

Site Status

Clinica, , Guatemala

Site Status

Edificio Multimedica, , Guatemala

Site Status

Nivel, , Guatemala

Site Status

Oficina, , Guatemala

Site Status

Quetzaltenango, , Guatemala

Site Status

Zacapa, , Guatemala

Site Status

Ajka, , Hungary

Site Status

Baja, , Hungary

Site Status

Békéscsaba, , Hungary

Site Status

Budapest, , Hungary

Site Status

Debrecen, , Hungary

Site Status

Hódmezővásárhely, , Hungary

Site Status

Kecskemét, , Hungary

Site Status

Keeskemet, , Hungary

Site Status

Kistarcsa, , Hungary

Site Status

Komárom, , Hungary

Site Status

Makó, , Hungary

Site Status

Nagykanizsa, , Hungary

Site Status

Nyíregyháza, , Hungary

Site Status

Pécs, , Hungary

Site Status

Sopron, , Hungary

Site Status

Szekszárd, , Hungary

Site Status

Szombathely, , Hungary

Site Status

Zalaegerszeg, , Hungary

Site Status

Hyderabad, Andhra Pradesh, India

Site Status

Vijayawada, Andhra Pradesh, India

Site Status

Angamaly, Kerala, India

Site Status

Kochi, Kerala, India

Site Status

Thrissur, Kerala, India

Site Status

Ahmedabad, , India

Site Status

Anddhra Pradesh, , India

Site Status

Andhra Pradesh, , India

Site Status

Aurangabad, , India

Site Status

Bangalore, , India

Site Status

Bikaner, , India

Site Status

Chennai, , India

Site Status

Coimbatore, , India

Site Status

Delhi, , India

Site Status

Gujrāt, , India

Site Status

Indore, , India

Site Status

Jaipur, , India

Site Status

Karnataka, , India

Site Status

Kerala, , India

Site Status

Kolkata, , India

Site Status

Ludhiana, , India

Site Status

Madhya Pradesh, , India

Site Status

Maharashtra, , India

Site Status

Mangalore, , India

Site Status

Mumbai, , India

Site Status

Nagpur, , India

Site Status

Nashik, , India

Site Status

New Delhi, , India

Site Status

Pune, , India

Site Status

Punjab, , India

Site Status

Pūni, , India

Site Status

Rajasthan, , India

Site Status

Ramnagar, , India

Site Status

Shimoga, , India

Site Status

Surat, , India

Site Status

Trivandrum, , India

Site Status

Vadodara, , India

Site Status

Afula, , Israel

Site Status

Beersheba, , Israel

Site Status

Dimona, , Israel

Site Status

Giv‘atayim, , Israel

Site Status

Hadera, , Israel

Site Status

Haifa, , Israel

Site Status

Holon, , Israel

Site Status

Jerusalem, , Israel

Site Status

Kfar Saba, , Israel

Site Status

Nahariya, , Israel

Site Status

Nazareth, , Israel

Site Status

Petah Tikva, , Israel

Site Status

Poria – Neve Oved, , Israel

Site Status

Raanana, , Israel

Site Status

Rehovot, , Israel

Site Status

Tel Aviv, , Israel

Site Status

Tel Litwinsky, , Israel

Site Status

Ẕerifin, , Israel

Site Status

Bologna, , Italy

Site Status

Brescia, , Italy

Site Status

Cantania, , Italy

Site Status

Casarano, , Italy

Site Status

Caserta, , Italy

Site Status

Chieti, , Italy

Site Status

Cremona, , Italy

Site Status

Genova, , Italy

Site Status

Grosseto, , Italy

Site Status

Legnano, , Italy

Site Status

Manerbio, , Italy

Site Status

Milan, , Italy

Site Status

Monserrato, , Italy

Site Status

Napoli, , Italy

Site Status

Novara, , Italy

Site Status

Ostia Antica, , Italy

Site Status

Pavia, , Italy

Site Status

Pisa, , Italy

Site Status

Pozzuoli, , Italy

Site Status

Roma, , Italy

Site Status

Santa Maria Capua Vetere, , Italy

Site Status

Sassari, , Italy

Site Status

Seriate, , Italy

Site Status

Siena, , Italy

Site Status

Trieste, , Italy

Site Status

Venezia Mestre, , Italy

Site Status

Kyoto, Kyoto, Japan

Site Status

Lida-shi, Nagano, Japan

Site Status

Ueda-shi, Nagano, Japan

Site Status

Minato-ku, Tokyo, Japan

Site Status

Aichi, , Japan

Site Status

Aomori, , Japan

Site Status

Chiaki, , Japan

Site Status

Chiba, , Japan

Site Status

Ehime, , Japan

Site Status

Fukuoka, , Japan

Site Status

Fukushima, , Japan

Site Status

Gifu, , Japan

Site Status

Gunma, , Japan

Site Status

Hiroshima, , Japan

Site Status

Hokkai-do, , Japan

Site Status

Hokkaido, , Japan

Site Status

Hyōgo, , Japan

Site Status

Ibaraki, , Japan

Site Status

Isesaki-shi, , Japan

Site Status

Ishikawa, , Japan

Site Status

Kagawa, , Japan

Site Status

Kanagawa, , Japan

Site Status

Kumamoto, , Japan

Site Status

Kyoda, , Japan

Site Status

Mie, , Japan

Site Status

Miyagi, , Japan

Site Status

Nagaoka-shi, , Japan

Site Status

Nagasaki, , Japan

Site Status

Niigata, , Japan

Site Status

Numakunai, , Japan

Site Status

Okayama, , Japan

Site Status

Osaka, , Japan

Site Status

Saitama, , Japan

Site Status

Shimane, , Japan

Site Status

Shizuoka, , Japan

Site Status

Tokushima, , Japan

Site Status

Tokyo, , Japan

Site Status

Yamaguchi, , Japan

Site Status

Yokohama, , Japan

Site Status

Guadalajara, Jalisco, Mexico

Site Status

Xalapa, Veracruz, Mexico

Site Status

Aguascalientes, , Mexico

Site Status

Chihuahua City, , Mexico

Site Status

Distrito Federal, , Mexico

Site Status

Durango, , Mexico

Site Status

Monterrey, , Mexico

Site Status

San Luis Potosí City, , Mexico

Site Status

Yucatán, , Mexico

Site Status

Almere Stad, , Netherlands

Site Status

Amstelveen, , Netherlands

Site Status

Amsterdam, , Netherlands

Site Status

Dordrecht, , Netherlands

Site Status

Eindhoven, , Netherlands

Site Status

Ewijk, , Netherlands

Site Status

Leiderdorp, , Netherlands

Site Status

Maastricht, , Netherlands

Site Status

Rotterdam, , Netherlands

Site Status

Venlo, , Netherlands

Site Status

Wildervlank, , Netherlands

Site Status

Lower Hutt, Wellington Region, New Zealand

Site Status

Auckland, , New Zealand

Site Status

Christchurch, , New Zealand

Site Status

Dunedin, , New Zealand

Site Status

Hamilton, , New Zealand

Site Status

Nelson, , New Zealand

Site Status

Tauranga, , New Zealand

Site Status

Bodø, , Norway

Site Status

Harstad, , Norway

Site Status

Haugesund, , Norway

Site Status

Oslo, , Norway

Site Status

Rud, , Norway

Site Status

Arequipa, , Peru

Site Status

Callao, , Peru

Site Status

Lima, , Peru

Site Status

Cebu, , Philippines

Site Status

Cebu City, , Philippines

Site Status

Davao City, , Philippines

Site Status

Pasig, , Philippines

Site Status

Quezon City, , Philippines

Site Status

Ostrów, Mazowiecka, Poland

Site Status

Bydgoszcz, , Poland

Site Status

Chojnice, , Poland

Site Status

Elblag, , Poland

Site Status

Ełk, , Poland

Site Status

Gdansk, , Poland

Site Status

Inowrocław, , Poland

Site Status

Jarosław, , Poland

Site Status

Katowice, , Poland

Site Status

Komenskiego, , Poland

Site Status

Kołobrzeg, , Poland

Site Status

Krakow, , Poland

Site Status

Kutno, , Poland

Site Status

Libiąż, , Poland

Site Status

Lodz, , Poland

Site Status

Lubartów, , Poland

Site Status

Lublin, , Poland

Site Status

Pomorskie, , Poland

Site Status

Puławy, , Poland

Site Status

Płock, , Poland

Site Status

Ruda Śląska, , Poland

Site Status

Rzeszów, , Poland

Site Status

Skierniewice, , Poland

Site Status

Sopot, , Poland

Site Status

Sucharskiego, , Poland

Site Status

Szczecin, , Poland

Site Status

Tarnów, , Poland

Site Status

Torun, , Poland

Site Status

Warsaw, , Poland

Site Status

Warzawa, , Poland

Site Status

Wroclaw, , Poland

Site Status

Amadora, , Portugal

Site Status

Aveiro, , Portugal

Site Status

Braga, , Portugal

Site Status

Coimbra, , Portugal

Site Status

Leiria, , Portugal

Site Status

Lisbon, , Portugal

Site Status

Ponta Delgada, , Portugal

Site Status

Setúbal, , Portugal

Site Status

Viseu, , Portugal

Site Status

Bacau, , Romania

Site Status

Brasov, , Romania

Site Status

Brăila, , Romania

Site Status

Buccuresti, , Romania

Site Status

Bucharest, , Romania

Site Status

Buzău, , Romania

Site Status

Covasna, , Romania

Site Status

Dambovita, , Romania

Site Status

Iași, , Romania

Site Status

Judetul Maramures, , Romania

Site Status

Judetul Mures, , Romania

Site Status

Judetul Suceava, , Romania

Site Status

Judetul Vrancea, , Romania

Site Status

Oradea, , Romania

Site Status

Timișoara, , Romania

Site Status

Barnaul, , Russia

Site Status

Chelyabinsk, , Russia

Site Status

Kemerovo, , Russia

Site Status

Krasnoyarsk, , Russia

Site Status

Moscow, , Russia

Site Status

Nizhny Novgorod, , Russia

Site Status

Novosibirsk, , Russia

Site Status

Omsk, , Russia

Site Status

Orenburg, , Russia

Site Status

Perm, , Russia

Site Status

Ryazan, , Russia

Site Status

Saint Petersburg, , Russia

Site Status

Saratov, , Russia

Site Status

Smolensk, , Russia

Site Status

Tula, , Russia

Site Status

Tyumen, , Russia

Site Status

Volgograd, , Russia

Site Status

Voronezh, , Russia

Site Status

Yaroslavl, , Russia

Site Status

Belgrade, , Serbia

Site Status

Kamenitz, , Serbia

Site Status

Niš, , Serbia

Site Status

Niška Banja, , Serbia

Site Status

Zemun, , Serbia

Site Status

Zmaj Jovina, , Serbia

Site Status

Bardejov, , Slovakia

Site Status

Bratislava, , Slovakia

Site Status

Dolný Kubín, , Slovakia

Site Status

Galanta, , Slovakia

Site Status

Košice, , Slovakia

Site Status

Levice, , Slovakia

Site Status

Lučenec, , Slovakia

Site Status

Nitra, , Slovakia

Site Status

Nové Zámky, , Slovakia

Site Status

Prešov, , Slovakia

Site Status

Rimavská Sobota, , Slovakia

Site Status

Alberton, , South Africa

Site Status

Benoni, , South Africa

Site Status

Bloemfontein, , South Africa

Site Status

Cape Town, , South Africa

Site Status

Diepkloof, , South Africa

Site Status

Durban, , South Africa

Site Status

Lyttelton, , South Africa

Site Status

Parktown West, , South Africa

Site Status

Port Elizabeth, , South Africa

Site Status

Potchefstroom, , South Africa

Site Status

Pretoria, , South Africa

Site Status

Somerset West, , South Africa

Site Status

Worcester, , South Africa

Site Status

Busan, , South Korea

Site Status

Daegu, , South Korea

Site Status

Daejeon, , South Korea

Site Status

Gangwon-do, , South Korea

Site Status

Gwangju, , South Korea

Site Status

Gyeonggi-do, , South Korea

Site Status

Incheon, , South Korea

Site Status

Pusan, , South Korea

Site Status

Seoul, , South Korea

Site Status

A Coruña, , Spain

Site Status

Alcoy, , Spain

Site Status

Almería, , Spain

Site Status

Barcelona, , Spain

Site Status

Bilbao, , Spain

Site Status

De La Castellana, , Spain

Site Status

Donostia / San Sebastian, , Spain

Site Status

Figueras, , Spain

Site Status

Jaén, , Spain

Site Status

Lleida, , Spain

Site Status

Madrid, , Spain

Site Status

Murcia, , Spain

Site Status

Santiago de Compostela, , Spain

Site Status

Seville, , Spain

Site Status

Vigo, , Spain

Site Status

Vitoria-Gasteiz, , Spain

Site Status

Alingsås, , Sweden

Site Status

Enköping, , Sweden

Site Status

Gothenburg, , Sweden

Site Status

Halmstad, , Sweden

Site Status

Karlshamn, , Sweden

Site Status

Köping, , Sweden

Site Status

Lindesberg, , Sweden

Site Status

Luleå, , Sweden

Site Status

Lund, , Sweden

Site Status

Malmo, , Sweden

Site Status

Mora, , Sweden

Site Status

Mölndal, , Sweden

Site Status

Örebro, , Sweden

Site Status

Skene, , Sweden

Site Status

Umeå, , Sweden

Site Status

Uppsala, , Sweden

Site Status

Varberg, , Sweden

Site Status

Lausanne, , Switzerland

Site Status

Lugano, , Switzerland

Site Status

Changhua, , Taiwan

Site Status

Hualien City, , Taiwan

Site Status

Kaohsiung City, , Taiwan

Site Status

Taichung, , Taiwan

Site Status

Taipei, , Taiwan

Site Status

Taoyuan, , Taiwan

Site Status

Yongkang District, , Taiwan

Site Status

Bangkok, , Thailand

Site Status

Chang Mai, , Thailand

Site Status

Khon Kaen, , Thailand

Site Status

Nakhon Ratchasima, , Thailand

Site Status

Pathum Thani, , Thailand

Site Status

Sai Mai, , Thailand

Site Status

Songkhla, , Thailand

Site Status

Adana, , Turkey (Türkiye)

Site Status

Ankara, , Turkey (Türkiye)

Site Status

Antalya, , Turkey (Türkiye)

Site Status

Aydin, , Turkey (Türkiye)

Site Status

Erzurum, , Turkey (Türkiye)

Site Status

Eskişehir, , Turkey (Türkiye)

Site Status

Isparta, , Turkey (Türkiye)

Site Status

Istanbul, , Turkey (Türkiye)

Site Status

Izmir, , Turkey (Türkiye)

Site Status

Konya, , Turkey (Türkiye)

Site Status

Sivas, , Turkey (Türkiye)

Site Status

Cherkasy, , Ukraine

Site Status

Chernihiv, , Ukraine

Site Status

Dnipropetrovsk, , Ukraine

Site Status

Donetsk, , Ukraine

Site Status

Ivano-Frankivsh, , Ukraine

Site Status

Ivano-Frankivsk, , Ukraine

Site Status

Kharkiv, , Ukraine

Site Status

Kherson, , Ukraine

Site Status

Kyiv, , Ukraine

Site Status

Luhansk, , Ukraine

Site Status

Lutsk, , Ukraine

Site Status

Lviv, , Ukraine

Site Status

Mykolayiv, , Ukraine

Site Status

Odesa, , Ukraine

Site Status

Poltava, , Ukraine

Site Status

Uzhhorod, , Ukraine

Site Status

Vinnytsia, , Ukraine

Site Status

Zaporizhzhya, , Ukraine

Site Status

Birmingham, , United Kingdom

Site Status

Blackpool, , United Kingdom

Site Status

Bournemouth, , United Kingdom

Site Status

Bradford, , United Kingdom

Site Status

Cambridge, , United Kingdom

Site Status

Chesterfield, , United Kingdom

Site Status

Coventry, , United Kingdom

Site Status

Devon, , United Kingdom

Site Status

Dundee, , United Kingdom

Site Status

East Horsley, , United Kingdom

Site Status

East Sussex, , United Kingdom

Site Status

Edinburgh, , United Kingdom

Site Status

Essex, , United Kingdom

Site Status

Glasgow, , United Kingdom

Site Status

Harrow, , United Kingdom

Site Status

Leicester, , United Kingdom

Site Status

Liverpool, , United Kingdom

Site Status

London, , United Kingdom

Site Status

Middlesbrough, , United Kingdom

Site Status

Orpington, , United Kingdom

Site Status

Peterborough, , United Kingdom

Site Status

Portadown, , United Kingdom

Site Status

Sheffield, , United Kingdom

Site Status

Stirling, , United Kingdom

Site Status

Stockport, , United Kingdom

Site Status

Surrey, , United Kingdom

Site Status

Sutton Coldfield, , United Kingdom

Site Status

Swindon, , United Kingdom

Site Status

Warwickshire, , United Kingdom

Site Status

Wolverhampton, , United Kingdom

Site Status

York, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Belgium Brazil Bulgaria Canada Chile China Colombia Croatia Czechia Denmark Estonia Finland France Germany Greece Guatemala Hungary India Israel Italy Japan Mexico Netherlands New Zealand Norway Peru Philippines Poland Portugal Romania Russia Serbia Slovakia South Africa South Korea Spain Sweden Switzerland Taiwan Thailand Turkey (Türkiye) Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Semco RS, Bergmark RW, Murphy SA, Cange AL, Unverdorben M, Chen CZL, Ruff CT, Antman EM, Giugliano RP, Bergmark BA. Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2025 Jan 21;14(2):e031434. doi: 10.1161/JAHA.123.031434. Epub 2025 Jan 10.

Reference Type DERIVED
PMID: 39791401 (View on PubMed)

Zimerman A, Braunwald E, Steffel J, Van Mieghem NM, Palazzolo MG, Murphy SA, Chen CZL, Unverdorben M, Ruff CT, Antman EM, Giugliano RP. Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial. JAMA Cardiol. 2024 Sep 1;9(9):817-825. doi: 10.1001/jamacardio.2024.1793.

Reference Type DERIVED
PMID: 38985461 (View on PubMed)

Bergmark BA, Park JG, Hamershock RA, Melloni GEM, De Caterina R, Antman EM, Ruff CT, Rutman H, Mercuri MF, Lanz HJ, Braunwald E, Giugliano RP. Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2024 Jul;17(7):e010561. doi: 10.1161/CIRCOUTCOMES.123.010561. Epub 2024 Jun 3.

Reference Type DERIVED
PMID: 38828563 (View on PubMed)

Inciardi RM, Giugliano RP, Park JG, Nordio F, Ruff CT, Chen C, Lanz HJ, Antman EM, Braunwald E, Solomon SD. Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes. JACC Clin Electrophysiol. 2023 Apr;9(4):569-580. doi: 10.1016/j.jacep.2022.11.032. Epub 2023 Feb 22.

Reference Type DERIVED
PMID: 37100536 (View on PubMed)

Oyama K, Giugliano RP, Ruff CT, Berg DD, Jarolim P, Tang M, Park JG, Lanz HJ, Antman EM, Braunwald E, Morrow DA. Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation. Eur J Heart Fail. 2023 Jun;25(6):832-841. doi: 10.1002/ejhf.2844. Epub 2023 Apr 18.

Reference Type DERIVED
PMID: 36987929 (View on PubMed)

Bonaca MP, Antman EM, Cunningham JW, Wiviott SD, Murphy SA, Halperin JL, Weitz JI, Grosso MA, Lanz HJ, Braunwald E, Giugliano RP, Ruff CT. Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):695-706. doi: 10.1093/ehjcvp/pvab089.

Reference Type DERIVED
PMID: 34962979 (View on PubMed)

Oyama K, Giugliano RP, Berg DD, Ruff CT, Jarolim P, Tang M, Murphy SA, Lanz HJ, Grosso MA, Antman EM, Braunwald E, Morrow DA. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2021 May 1;42(17):1698-1706. doi: 10.1093/eurheartj/ehab141.

Reference Type DERIVED
PMID: 33760027 (View on PubMed)

Steffel J, Ruff CT, Yin O, Braunwald E, Park JG, Murphy SA, Connolly S, Antman EM, Giugliano RP. Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation. J Am Coll Cardiol. 2021 Mar 9;77(9):1197-1207. doi: 10.1016/j.jacc.2020.12.053.

Reference Type DERIVED
PMID: 33663737 (View on PubMed)

Wilkinson C, Wu J, Searle SD, Todd O, Hall M, Kunadian V, Clegg A, Rockwood K, Gale CP. Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial. BMC Med. 2020 Dec 24;18(1):401. doi: 10.1186/s12916-020-01870-w.

Reference Type DERIVED
PMID: 33357217 (View on PubMed)

Vilain K, Li H, Kwong WJ, Antman EM, Ruff CT, Braunwald E, Cohen DJ, Giugliano RP, Magnuson EA; ENGAGE AF-TIMI 48 Trial Investigators. Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF-TIMI 48 Trial. Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e006511. doi: 10.1161/CIRCOUTCOMES.120.006511. Epub 2020 Nov 5.

Reference Type DERIVED
PMID: 33148013 (View on PubMed)

Inciardi RM, Giugliano RP, Claggett B, Gupta DK, Chandra A, Ruff CT, Antman EM, Mercuri MF, Grosso MA, Braunwald E, Solomon SD; ENGAGE AF-TIMI 48 Investigators. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation. Eur J Heart Fail. 2019 Dec;21(12):1571-1579. doi: 10.1002/ejhf.1606. Epub 2019 Nov 27.

Reference Type DERIVED
PMID: 31777160 (View on PubMed)

Bergmark BA, Kamphuisen PW, Wiviott SD, Ruff CT, Antman EM, Nordio F, Kuder JF, Mercuri MF, Lanz HJ, Braunwald E, Giugliano RP. Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial. Circulation. 2019 Nov 26;140(22):1792-1801. doi: 10.1161/CIRCULATIONAHA.119.041346. Epub 2019 Oct 10.

Reference Type DERIVED
PMID: 31597460 (View on PubMed)

Berg DD, Ruff CT, Jarolim P, Giugliano RP, Nordio F, Lanz HJ, Mercuri MF, Antman EM, Braunwald E, Morrow DA. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48. Circulation. 2019 Feb 5;139(6):760-771. doi: 10.1161/CIRCULATIONAHA.118.038312.

Reference Type DERIVED
PMID: 30586727 (View on PubMed)

Corbalan R, Nicolau JC, Lopez-Sendon J, Garcia-Castillo A, Botero R, Sotomora G, Horna M, Ruff CT, Hamershock RA, Grip LT, Antman EM, Braunwald E, Giugliano RP. Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial. J Am Coll Cardiol. 2018 Sep 25;72(13):1466-1475. doi: 10.1016/j.jacc.2018.07.037.

Reference Type DERIVED
PMID: 30236308 (View on PubMed)

Yin OQP, Antman EM, Braunwald E, Mercuri MF, Miller R, Morrow D, Ruff CT, Truitt K, Weitz JI, Giugliano RP. Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial. Circulation. 2018 Oct 30;138(18):1963-1973. doi: 10.1161/CIRCULATIONAHA.118.033933.

Reference Type DERIVED
PMID: 29967197 (View on PubMed)

Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, Weitz JI, Ruff CT, Nordio F, Mercuri MF, Choi Y, Antman EM, Braunwald E, Giugliano RP. Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction). Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e003998. doi: 10.1161/CIRCOUTCOMES.117.003998.

Reference Type DERIVED
PMID: 29748353 (View on PubMed)

Wang K, Li H, Kwong WJ, Antman EM, Ruff CT, Giugliano RP, Cohen DJ, Magnuson EA; ENGAGE AF-TIMI 48 Trial Investigators. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2017 Aug 11;6(8):e006703. doi: 10.1161/JAHA.117.006703.

Reference Type DERIVED
PMID: 28862934 (View on PubMed)

Eisen A, Ruff CT, Braunwald E, Hamershock RA, Lewis BS, Hassager C, Chao TF, Le Heuzey JY, Mercuri M, Rutman H, Antman EM, Giugliano RP. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2017 Jun 30;6(7):e006035. doi: 10.1161/JAHA.117.006035.

Reference Type DERIVED
PMID: 28666993 (View on PubMed)

De Caterina R, Renda G, Carnicelli AP, Nordio F, Trevisan M, Mercuri MF, Ruff CT, Antman EM, Braunwald E, Giugliano RP. Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial. J Am Coll Cardiol. 2017 Mar 21;69(11):1372-1382. doi: 10.1016/j.jacc.2016.12.031.

Reference Type DERIVED
PMID: 28302288 (View on PubMed)

Link MS, Giugliano RP, Ruff CT, Scirica BM, Huikuri H, Oto A, Crompton AE, Murphy SA, Lanz H, Mercuri MF, Antman EM, Braunwald E; ENGAGE AF-TIMI 48 Investigators. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Circ Arrhythm Electrophysiol. 2017 Jan;10(1):e004267. doi: 10.1161/CIRCEP.116.004267.

Reference Type DERIVED
PMID: 28077507 (View on PubMed)

Ruff CT, Giugliano RP, Braunwald E, Murphy SA, Brown K, Jarolim P, Mercuri M, Antman EM, Morrow DA. Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial. JAMA Cardiol. 2016 Dec 1;1(9):999-1006. doi: 10.1001/jamacardio.2016.3311.

Reference Type DERIVED
PMID: 27706467 (View on PubMed)

Steffel J, Giugliano RP, Braunwald E, Murphy SA, Mercuri M, Choi Y, Aylward P, White H, Zamorano JL, Antman EM, Ruff CT. Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis. J Am Coll Cardiol. 2016 Sep 13;68(11):1169-1178. doi: 10.1016/j.jacc.2016.06.034.

Reference Type DERIVED
PMID: 27609678 (View on PubMed)

Eisen A, Ruff CT, Braunwald E, Nordio F, Corbalan R, Dalby A, Dorobantu M, Mercuri M, Lanz H, Rutman H, Wiviott SD, Antman EM, Giugliano RP. Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2016 Jul 8;5(7):e003735. doi: 10.1161/JAHA.116.003735.

Reference Type DERIVED
PMID: 27402235 (View on PubMed)

Rost NS, Giugliano RP, Ruff CT, Murphy SA, Crompton AE, Norden AD, Silverman S, Singhal AB, Nicolau JC, SomaRaju B, Mercuri MF, Antman EM, Braunwald E; ENGAGE AF-TIMI 48 Investigators. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48). Stroke. 2016 Aug;47(8):2075-82. doi: 10.1161/STROKEAHA.116.013540. Epub 2016 Jul 7.

Reference Type DERIVED
PMID: 27387994 (View on PubMed)

Bohula EA, Giugliano RP, Ruff CT, Kuder JF, Murphy SA, Antman EM, Braunwald E. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial. Circulation. 2016 Jul 5;134(1):24-36. doi: 10.1161/CIRCULATIONAHA.116.022361.

Reference Type DERIVED
PMID: 27358434 (View on PubMed)

Kato ET, Giugliano RP, Ruff CT, Koretsune Y, Yamashita T, Kiss RG, Nordio F, Murphy SA, Kimura T, Jin J, Lanz H, Mercuri M, Braunwald E, Antman EM. Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc. 2016 May 20;5(5):e003432. doi: 10.1161/JAHA.116.003432.

Reference Type DERIVED
PMID: 27207971 (View on PubMed)

Xu H, Ruff CT, Giugliano RP, Murphy SA, Nordio F, Patel I, Shi M, Mercuri M, Antman EM, Braunwald E. Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial. J Am Heart Assoc. 2016 Feb 23;5(2):e002587. doi: 10.1161/JAHA.115.002587.

Reference Type DERIVED
PMID: 26908401 (View on PubMed)

Ruff CT, Giugliano RP, Braunwald E, Morrow DA, Murphy SA, Kuder JF, Deenadayalu N, Jarolim P, Betcher J, Shi M, Brown K, Patel I, Mercuri M, Antman EM. Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet. 2015 Jun 6;385(9984):2288-95. doi: 10.1016/S0140-6736(14)61943-7. Epub 2015 Mar 11.

Reference Type DERIVED
PMID: 25769361 (View on PubMed)

Mega JL, Walker JR, Ruff CT, Vandell AG, Nordio F, Deenadayalu N, Murphy SA, Lee J, Mercuri MF, Giugliano RP, Antman EM, Braunwald E, Sabatine MS. Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet. 2015 Jun 6;385(9984):2280-7. doi: 10.1016/S0140-6736(14)61994-2. Epub 2015 Mar 11.

Reference Type DERIVED
PMID: 25769357 (View on PubMed)

Ruff CT, Giugliano RP, Braunwald E, Mercuri M, Curt V, Betcher J, Grip L, Cange AL, Crompton AE, Murphy SA, Deenadayalu N, Antman EM. Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial. J Am Coll Cardiol. 2014 Aug 12;64(6):576-84. doi: 10.1016/j.jacc.2014.05.028.

Reference Type DERIVED
PMID: 25104527 (View on PubMed)

Giugliano RP, Ruff CT, Rost NS, Silverman S, Wiviott SD, Lowe C, Deenadayalu N, Murphy SA, Grip LT, Betcher JM, Duggal A, Dave J, Shi M, Mercuri M, Antman EM, Braunwald E; ENGAGE AF-TIMI 48 Investigators. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48. Stroke. 2014 Aug;45(8):2372-8. doi: 10.1161/STROKEAHA.114.006025. Epub 2014 Jun 19.

Reference Type DERIVED
PMID: 24947287 (View on PubMed)

Gupta DK, Shah AM, Giugliano RP, Ruff CT, Antman EM, Grip LT, Deenadayalu N, Hoffman E, Patel I, Shi M, Mercuri M, Mitrovic V, Braunwald E, Solomon SD; Effective aNticoaGulation with factor xA next GEneration in AF-Thrombolysis In Myocardial Infarction 48 Echocardiographic Study Investigators. Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Eur Heart J. 2014 Jun 7;35(22):1457-65. doi: 10.1093/eurheartj/eht500. Epub 2013 Dec 2.

Reference Type DERIVED
PMID: 24302269 (View on PubMed)

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.

Reference Type DERIVED
PMID: 24251359 (View on PubMed)

Salazar DE, Mendell J, Kastrissios H, Green M, Carrothers TJ, Song S, Patel I, Bocanegra TS, Antman EM, Giugliano RP, Kunitada S, Dornseif B, Shi M, Tachibana M, Zhou S, Rohatagi S. Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation. Thromb Haemost. 2012 May;107(5):925-36. doi: 10.1160/TH11-08-0566. Epub 2012 Mar 8.

Reference Type DERIVED
PMID: 22398655 (View on PubMed)

Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, Hanyok J, Patel I, Shi M, Salazar D, McCabe CH, Braunwald E. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J. 2010 Oct;160(4):635-41. doi: 10.1016/j.ahj.2010.06.042.

Reference Type DERIVED
PMID: 20934556 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DU176b-C-U301

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.